皮膚科市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、エンドユーザー別、地域別、競合別、2020～2030年

皮膚科の世界市場規模は2024年に13億2,000万米ドルで、予測期間中のCAGRは6.62%で2030年には19億2,000万米ドルに達すると予測されています。

世界の皮膚科市場はダイナミックで急速に発展している分野であり、皮膚に関連する様々な症状や障害に対処する上で極めて重要な役割を果たしています。技術の進歩、認知度の向上、高齢化人口の増加といった特徴を持つ皮膚科市場は、近年大きな成長を遂げています。同市場は、医薬品や生物製剤から診断機器や美容介入に至るまで、幅広い製品とサービスを包含しています。皮膚科市場の拡大に拍車をかけている主な要因の一つは、皮膚炎、乾癬、にきび、皮膚がんなどの皮膚疾患の罹患率が上昇し、効果的な治療オプションに対する需要が高まっていることです。さらに、若々しく健康的な肌を求める消費者の増加により、美容施術や化粧品皮膚科が重視されるようになり、市場成長に大きく寄与しています。

従来の治療法に加え、技術革新が標的生物学的製剤や個別化医療などの新規治療法の開発に拍車をかけ、皮膚科治療の様相を一変させています。市場は研究開発活動の急増を目の当たりにしており、革新的な治療法や治療方法の発見を後押ししています。地域的には、北米と欧州が伝統的に大きな市場シェアを占めてきました。これは、高度なヘルスケア・インフラ、皮膚疾患の高い有病率、スキンケアへの積極的なアプローチによるものです。しかし、アジア太平洋とラテンアメリカの新興国は、中間層の拡大、可処分所得の増加、皮膚科学的健康に対する意識の高まりなどを背景に、急速に牽引力を増しています。

市場参入企業の間では、コラボレーション、パートナーシップ、戦略的買収が、市場の足場を固め、製品ポートフォリオを拡大するための一般的な戦略となっています。全体として、世界の皮膚科市場は、人口動態の動向、技術の進歩、消費者の嗜好の進化に後押しされ、継続的な成長が見込まれており、より広範なヘルスケア産業の中で重要かつ活気のある分野となっています。

市場促進要因

世界の皮膚疾患の増加

技術の進歩

美容施術に対する意識の高まり

主な市場課題

皮膚科治療に伴う経済的負担

規制上のハードル

主要市場動向

美容施術と皮膚科手術の急増

遠隔皮膚科の技術統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の皮膚科市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（内科皮膚科、外科皮膚科、小児皮膚科、美容皮膚科、皮膚リンパ腫、皮膚免疫学、その他）
  • 用途別（ニキビ、皮膚炎、乾癬、皮膚がん、酒さ、脱毛症、その他）
  • エンドユーザー別（病院・診療所、外来手術センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の皮膚科市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の皮膚科市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の皮膚科市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の皮膚科市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの皮膚科市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の皮膚科市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• AbbVie Inc.
• Pfizer Inc.
• GSK plc
• LEO Pharma A/S
• Sun Pharmaceutical Industries Ltd
• Galderma S.A.
• Amgen Inc.
• DermBiont, Inc.
• Johnson & Johnson Services Inc.
• Roivant Sciences Ltd.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Dermatology Market was valued at USD 1.32 Billion in 2024 and is expected to reach USD 1.92 Billion by 2030 with a CAGR of 6.62% during the forecast period. The global dermatology market is a dynamic and rapidly evolving sector that plays a pivotal role in addressing a wide array of skin-related conditions and disorders. Characterized by a robust combination of technological advancements, increasing awareness, and a growing aging population, the dermatology market has witnessed substantial growth in recent years. The market encompasses a broad spectrum of products and services, ranging from pharmaceuticals and biologics to diagnostic devices and cosmetic interventions. One of the key drivers fueling the expansion of the dermatology market is the rising incidence of skin diseases, including dermatitis, psoriasis, acne, and skin cancer, necessitating a heightened demand for effective treatment options. Furthermore, the growing emphasis on aesthetic procedures and cosmetic dermatology has contributed significantly to market growth, driven by the increasing consumer desire for youthful and healthy skin.

In addition to traditional treatments, technological innovations have spurred the development of novel therapies, such as targeted biologics and personalized medicine, transforming the landscape of dermatological care. The market is witnessing a surge in research and development activities, fostering the discovery of innovative therapies and treatment modalities. Geographically, North America and Europe have traditionally held substantial market shares, owing to advanced healthcare infrastructure, a high prevalence of skin disorders, and a proactive approach to skincare. However, emerging economies in Asia-Pacific and Latin America are rapidly gaining traction, driven by an expanding middle-class population, rising disposable income, and increasing awareness about dermatological health.

Collaborations, partnerships, and strategic acquisitions are prevalent strategies among industry participants to strengthen their market foothold and expand their product portfolios. Overall, the global dermatology market is poised for continued growth, fueled by a combination of demographic trends, technological advancements, and evolving consumer preferences, making it a vital and vibrant sector within the broader healthcare industry.

Key Market Drivers

Increasing Incidence of Skin Disorders Worldwide

The global dermatology market is witnessing a substantial boost, driven in large part by the increasing incidence of skin disorders worldwide. Skin conditions, ranging from common ailments like dermatitis and acne to more serious issues such as psoriasis and skin cancer, have become more prevalent across diverse demographics. This upsurge can be attributed to a combination of factors, including environmental changes, lifestyle choices, and genetic predispositions. As the global population expands and ages, there is a parallel rise in the demand for effective dermatological treatments and interventions. According to the World Health Organization (WHO), skin conditions impact approximately 1.8 billion people globally at any given time. In tropical and resource-limited regions, skin infections, which may be caused by bacterial, viral, fungal, or parasitic agents, are the most common source of disease. In many communities, neglected tropical diseases (NTDs) account for about 10% of all skin conditions. The growing incidence of these conditions, alongside rising awareness of dermatological health, is fueling demand for advanced dermatology treatments and solutions. This trend is expected to further accelerate market growth as both developed and developing regions seek to address the increasing burden of skin-related health issues.

The prevalence of skin disorders has become a significant public health concern, prompting a heightened focus on dermatology as a crucial facet of healthcare. Skin conditions not only impact physical well-being but also carry a substantial psychological and emotional burden. This has led to an increased awareness among individuals about the importance of seeking professional dermatological care, thereby driving the demand for dermatological products and services. As a result, the pharmaceutical industry is responding with a growing array of medications, including topical treatments, oral medications, and biologics, designed to address specific skin conditions and improve patient outcomes.

The surge in skin disorders is also influencing the development of advanced diagnostic technologies and treatment modalities within the dermatology market. Innovations such as telemedicine and digital health platforms are facilitating improved access to dermatological expertise, enabling patients to seek consultations remotely. Moreover, the integration of artificial intelligence and machine learning in dermatological diagnostics is enhancing the accuracy and efficiency of disease detection. Early diagnosis is crucial in managing skin disorders effectively, and these technological advancements contribute significantly to the overall growth and competitiveness of the dermatology market.

The global dermatology market is witnessing a paradigm shift not only in response to the increasing prevalence of skin disorders but also due to changing societal perceptions. The recognition of the impact of skin conditions on quality of life has fueled a growing demand for cosmetic dermatology procedures. Individuals are seeking aesthetic treatments to address concerns related to aging, pigmentation, and overall skin appearance. This burgeoning interest in cosmetic interventions, including injectables, laser therapies, and surgical procedures, is opening new avenues for dermatologists and contributing to the diversification of the dermatology market.

Technological Advancements

Technological advancements are playing a transformative role in propelling the global dermatology market to new heights. The integration of cutting-edge technologies has significantly enhanced the diagnosis, treatment, and overall management of dermatological conditions, fostering a paradigm shift in healthcare solutions. One of the notable contributions comes from the realm of telemedicine and digital health platforms, which have revolutionized the way dermatological care is delivered. These technologies enable remote consultations, allowing patients to access specialized dermatological expertise regardless of geographical barriers. This not only enhances patient convenience but also facilitates timely interventions and reduces the burden on traditional healthcare infrastructures.

In the field of diagnostics, technological innovations have brought about remarkable improvements in accuracy and efficiency. Techniques such as dermoscopy and reflectance confocal microscopy have revolutionized skin cancer diagnosis, providing dermatologists with powerful tools for early detection and precise assessment. Artificial intelligence (AI) and machine learning algorithms are being increasingly employed to analyze dermatological images, assisting in the identification of patterns indicative of various skin conditions. This not only aids in faster and more accurate diagnostics but also contributes to the overall efficiency of dermatological care.

Moreover, advancements in treatment modalities are reshaping the therapeutic landscape of dermatology. Targeted biologics, personalized medicine, and innovative pharmaceuticals are emerging as more effective and precise interventions for various skin disorders. These developments signify a shift toward customized treatment plans, addressing individual patient needs and characteristics. The market is witnessing a surge in research and development activities aimed at discovering novel therapies that leverage the latest scientific and technological breakthroughs, thereby expanding the array of options available to dermatologists and their patients.

The incorporation of technology also extends to patient education and engagement. Digital platforms and mobile applications provide valuable resources for individuals seeking information on skincare, preventive measures, and treatment options. These tools empower patients to actively participate in their dermatological care, fostering a collaborative approach between healthcare providers and patients. The increased accessibility to information contributes to heightened awareness about skin health, leading to proactive measures and early intervention.

Increasing Awareness of Aesthetic Dermatology Procedures

Aesthetic concerns and the desire for enhanced physical appearance have become prominent factors influencing consumer choices in the realm of dermatological interventions. Individuals are increasingly seeking cosmetic dermatology procedures to address a variety of aesthetic issues, including signs of aging, pigmentation irregularities, and overall skin quality. This heightened awareness is fueling a surge in demand for a diverse range of aesthetic treatments, ranging from minimally invasive procedures such as injectables and laser therapies to more extensive surgical interventions. Increasing awareness of aesthetic dermatology procedures is driving growth in the sector, particularly with innovations like AviClear, a breakthrough FDA-cleared energy-based device for long-term treatment of mild to severe inflammatory acne. In June 2024, Cutera, Inc. released significant new survey data during Acne Awareness Month, highlighting the emotional and social impact of acne on individuals and underscoring the effectiveness of novel treatments. The survey revealed that 90% of acne sufferers experience daily insecurities, 43% fear they will never achieve clear skin, and 60% find the challenges of treating acne can be more distressing than the acne itself. Furthermore, half of those familiar with AviClear expressed interest in trying it. To further engage stakeholders, Cutera hosted an investor webinar in June 2024, providing an in-depth review of clinical data, market potential, ongoing and future clinical studies, and real-world user experiences. This increasing awareness of both the emotional impact of skin conditions and the availability of advanced treatments is fueling demand for aesthetic dermatology procedures, contributing to the broader market expansion.

The growing acceptance of aesthetic dermatology is reshaping the market dynamics, with a notable shift in consumer preferences towards treatments that offer natural-looking results and minimal downtime. The market response to this trend has been the development of advanced and innovative cosmetic interventions designed to cater to diverse patient needs. Injectables like botulinum toxin and dermal fillers are witnessing a robust demand, providing non-surgical options for facial rejuvenation and volume restoration. Laser and light-based therapies are gaining popularity for addressing skin imperfections and promoting collagen production. Additionally, surgical procedures such as facelifts and body contouring are becoming more commonplace as individuals seek comprehensive solutions for aesthetic enhancement.

The rise in awareness of aesthetic dermatology is not only influencing individual choices but is also driving the growth of specialized dermatology practices and clinics dedicated to cosmetic procedures. Dermatologists and healthcare professionals are adapting to this evolving landscape by expanding their expertise and offering a broader array of aesthetic services. The market is witnessing a convergence of medical and cosmetic dermatology, with practitioners adopting a holistic approach to address both medical and aesthetic concerns, thereby catering to the diverse needs of their patient base. Furthermore, the influence of social media and digital platforms is playing a pivotal role in spreading awareness about aesthetic dermatology procedures. Before-and-after photos, patient testimonials, and educational content shared on these platforms contribute to an informed and engaged audience. Patients are increasingly researching and seeking information online, leading to a more educated consumer base that actively participates in decisions related to their aesthetic treatments.

Key Market Challenges

Economic Burden Associated with Dermatological Treatments

The economic burden associated with dermatological treatments stands out as a significant impediment hindering the global dermatology market. As the market witnesses the emergence of cutting-edge therapies, including biologics and advanced pharmaceuticals, the high costs of research, development, and production contribute to elevated pricing, limiting accessibility for a substantial portion of the population.

In developed countries, where healthcare resources are relatively abundant, the economic challenge manifests in the form of high out-of-pocket expenses for patients seeking dermatological care. The affordability of these treatments becomes a pressing concern, especially for those without comprehensive insurance coverage. This economic barrier not only restricts patient access to innovative therapies but also places a strain on healthcare systems, leading to disparities in the quality of dermatological care based on socioeconomic factors.

In developing nations, the economic burden poses an even more formidable challenge. Limited healthcare resources and infrastructure, coupled with a lack of insurance coverage, make advanced dermatological treatments a luxury rather than a necessity for many individuals. Skin disorders, which can significantly impact quality of life, often go untreated due to financial constraints. This not only results in prolonged suffering for affected individuals but also contributes to the overall burden of untreated dermatological conditions on public health.

Regulatory hurdles

Regulatory hurdles are a formidable obstacle impeding the seamless growth of the global dermatology market. The journey from the inception of innovative dermatological products to their commercialization is often prolonged and arduous due to stringent regulatory requirements. While these regulations are crucial for ensuring the safety and efficacy of dermatological treatments, the complex and time-consuming approval processes can significantly delay the introduction of novel solutions to the market.

The regulatory landscape for dermatological products is characterized by rigorous testing and documentation requirements. Pharmaceutical companies and manufacturers must adhere to strict protocols to demonstrate the safety and effectiveness of their products before gaining regulatory approval. This meticulous approach, while essential for protecting patient well-being, inevitably extends the time and resources required for bringing new dermatological therapies to market.

Additionally, the divergent regulatory standards across different regions and countries present a significant challenge for industry players aiming for global market penetration. Navigating the intricacies of varied regulatory frameworks demands substantial investments in legal and regulatory affairs expertise, further complicating the pathway to market approval. The variations in regulatory standards not only extend the timelines for product approvals but also create barriers to entry, limiting the accessibility of innovative dermatological treatments for patients in certain regions.

Key Market Trends

Surge in Cosmetic Procedures and Dermatological Surgeries

The global dermatology market is experiencing a surge driven by the increasing demand for cosmetic procedures and dermatological surgeries. This trend is indicative of a cultural shift where individuals are placing a higher emphasis on aesthetic enhancements and skin rejuvenation. Non-invasive cosmetic procedures, such as injectables (e.g., dermal fillers and neurotoxins like Botox) and laser therapies, have become immensely popular due to their effectiveness in addressing signs of aging and enhancing facial features. The allure of these minimally invasive treatments lies in their ability to deliver noticeable results with minimal downtime, catering to individuals seeking quick and convenient solutions for aesthetic improvements. The surge in cosmetic procedures and dermatological surgeries is evident, with significant increases in demand for popular treatments. According to the American Society of Plastic Surgeons' 2023 statistics, liposuction remained the most requested plastic surgery procedure in 2023, with 347,782 procedures performed marking a 7% increase from the previous year. Similarly, tummy tucks experienced a 5% rise, with 170,110 procedures performed, reflecting continued interest in body contouring and lower abdomen tightening. Additionally, breast augmentation procedures, including both primary and revision implants, totaled 304,181 in 2023. These growing trends highlight the increasing consumer demand for aesthetic enhancements and body transformations, contributing to the overall expansion of the cosmetic and dermatological surgery markets.

Dermatological surgeries, including facelifts, eyelid surgery, and liposuction, are also on the rise. These procedures offer more comprehensive and long-lasting results, addressing a range of concerns beyond what non-invasive treatments can achieve. The increasing acceptance and destigmatization of cosmetic procedures contribute to a growing patient pool opting for dermatological surgeries to achieve their desired aesthetic outcomes. Moreover, advancements in surgical techniques and technology have made these procedures safer and more accessible, attracting a broader demographic of patients.

The surge in cosmetic procedures and dermatological surgeries is driven by a desire for enhanced self-esteem and confidence, coupled with a societal appreciation for aesthetic diversity. As the global population ages, there is a heightened awareness of the impact of aging on one's appearance, fueling the demand for anti-aging solutions. The influence of social media, where visual representation holds significant value, further contributes to the popularity of cosmetic interventions.

Technological Integration in Teledermatology

The global dermatology market is experiencing a significant boost propelled by the integration of technology, particularly in the realm of teledermatology. This innovative approach to dermatological care involves the use of digital platforms and telecommunication technologies to facilitate remote consultations, diagnosis, and treatment planning. The convergence of technology and dermatology not only addresses barriers to traditional healthcare access but also enhances the overall efficiency and reach of dermatological services.

Teledermatology is reshaping patient care by allowing individuals to consult with dermatologists from the comfort of their homes. This is particularly advantageous in areas with limited access to specialized dermatological services or during situations like the COVID-19 pandemic, where in-person visits may be challenging. The integration of high-quality imaging tools, such as dermo scopes, enables patients to capture and share images of skin conditions with dermatologists, facilitating accurate and timely remote assessments.

Furthermore, the rise of artificial intelligence (AI) and machine learning in teledermatology is revolutionizing the diagnostic process. These technologies analyze dermatological images, aiding in the identification of patterns indicative of various skin conditions. The automation of certain diagnostic tasks not only enhances the accuracy of assessments but also expedites the overall diagnostic process, contributing to timely and effective patient care. In November 2024, a research team from Google developed an artificial intelligence (AI) system capable of accurately detecting 26 different skin diseases with the same level of precision as a licensed dermatologist. This deep learning technology analyzes images and associated metadata, including self-reported symptoms and demographic details, to generate a ranked list of potential diagnoses, similar to the process followed by trained healthcare professionals. The team's findings were published in a paper titled "A Deep Learning System for Differential Diagnosis of Skin Diseases" and also highlighted in a blog post authored by Yuan Liu, PhD, Software Engineer, and Peggy Bui, MD, Technical Program Manager at Google Health. The global adoption of Teledermatology is facilitated by the increasing prevalence of smartphones and internet connectivity. Mobile applications and telehealth platforms dedicated to dermatology provide patients with user-friendly interfaces, allowing them to schedule virtual appointments, share images securely, and receive expert guidance. This technological integration not only improves patient convenience but also fosters a proactive approach to skincare, as individuals can seek dermatological advice promptly.

Segmental Insights

Type Insights

Based on type, the Cosmetic Dermatology emerged as the fastest growing segment in the global market for Dermatology during the forecast period. As awareness of skincare and personal appearance continues to grow, there is an increasing demand for cosmetic treatments aimed at improving skin health and addressing aesthetic concerns such as wrinkles, acne scars, and signs of aging. The rise of media exposure, social media influencers, and the greater availability of information have all contributed to heightened awareness of available cosmetic procedures. Cosmetic dermatology encompasses non-surgical treatments like Botox, dermal fillers, chemical peels, and laser skin resurfacing, which deliver effective results with minimal recovery time. According to the American Society of Plastic Surgeons' 2023 statistics, 4,715,716 botulinum toxin type A procedures (including Botox, Dysport, and Xeomin) were performed, marking a 6% increase from the previous year. Dermal fillers also saw substantial growth, with 3,441,534 procedures performed, a 4% rise from 2022. These treatments are viewed as safer and more affordable alternatives to traditional surgery, making them increasingly popular among individuals seeking less invasive options for enhancing their appearance. Furthermore, advancements in dermatological technology, such as more precise laser treatments and non-invasive fat reduction techniques, have improved both the safety and effectiveness of these procedures, making them more accessible to a wider consumer base. With the growing cultural focus on self-care and well-being, people are more willing to invest in treatments that improve their appearance and self-confidence, thereby expanding the market for cosmetic dermatology. Social media platforms like Instagram and TikTok, where beauty and aesthetics are prominently featured, have also played a significant role in driving demand for these procedures, with users often sharing their experiences and contributing to greater visibility and acceptance of cosmetic dermatology treatments.

Application Insights

Based on application, Acne emerged as the dominating segment in the global market for Dermatology in 2024. Acne is one of the most common skin conditions, affecting both adolescents and a significant number of adults. It is estimated that up to 85% of individuals will experience acne at some point in their lives, creating a substantial and consistent demand for both over-the-counter and professional dermatological treatments. Acne's impact extends beyond physical symptoms, often affecting self-esteem and social interactions, which drives individuals to seek both preventive and corrective solutions. Advancements in acne treatments, from basic topical solutions to more sophisticated options like oral medications, laser therapy, and light-based treatments, have further boosted market demand. Increased awareness through digital platforms, social media, and influencers has contributed to growing consumer knowledge about acne and treatment options, fostering a demand for personalized care. The rise of teledermatology and e-commerce has expanded access to these treatments, making them more accessible to a broader audience. As a result, acne remains the dominant segment in the global dermatology market.

Regional Insights

Based on Region, North America emerged as the dominant region in the Global Dermatology Market in 2024. The demand for cosmetic dermatology treatments, including Botox, dermal fillers, and laser procedures, is strong in North America, driven by high consumer awareness and disposable income. A growing focus on aesthetics and self-care has led to increased demand for non-invasive dermatological solutions. According to the American Academy of Dermatology, acne remains the most prevalent skin condition in the U.S., affecting up to 50 million Americans annually, while psoriasis impacts approximately 7.5 million people. The high incidence of skin conditions such as acne, eczema, and skin cancer further fuels market growth, with increasing awareness and educational campaigns highlighting treatment options. North America boasts well-developed healthcare systems with access to advanced technologies and skilled dermatologists, facilitating the expansion of the dermatology market. The region's robust medical infrastructure supports a wide array of treatments, including medical, cosmetic, and surgical dermatology. Additionally, the aging population and cultural emphasis on youth and beauty drive demand for anti-aging treatments, such as wrinkle reduction and skin tightening. Access to health insurance in the U.S. and Canada also enhances the availability of dermatology services, making treatments like skin cancer or psoriasis care more accessible to a broader population.

Key Market Players

• AbbVie Inc.
• Pfizer Inc.
• GSK plc
• LEO Pharma A/S
• Sun Pharmaceutical Industries Ltd
• Galderma S.A.
• Amgen Inc.
• DermBiont, Inc.
• Johnson & Johnson Services Inc.
• Roivant Sciences Ltd.

Report Scope:

In this report, the Global Dermatology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatology Market, By Type:

• Medical Dermatology
• Surgical Dermatology
• Pediatric Dermatology
• Cosmetic Dermatology
• Cutaneous Lymphoma
• Dermatoimmunology
• Others

Dermatology Market, By Application:

• Acne
• Dermatitis
• Psoriasis
• Skin Cancer
• Rosacea
• Alopecia
• Others

Dermatology Market, By Application:

• Acne
• Dermatitis
• Psoriasis
• Skin Cancer
• Rosacea
• Alopecia
• Others

Dermatology Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Dermatology Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatology Market.

Available Customizations:

Global Dermatology Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Dermatology Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Medical Dermatology, Surgical Dermatology, Pediatric Dermatology, Cosmetic Dermatology, Cutaneous Lymphoma, Dermatoimmunology, Others)
  • 4.2.2. By Application (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia, Others)
  • 4.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Application
  • 4.3.3. By End User
  • 4.3.4. By Region

5. Asia Pacific Dermatology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Application
  • 5.2.3. By End User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Dermatology Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By End User
  • 5.3.2. India Dermatology Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Application
      • 5.3.2.2.3. By End User
  • 5.3.3. Australia Dermatology Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By End User
  • 5.3.4. Japan Dermatology Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Application
      • 5.3.4.2.3. By End User
  • 5.3.5. South Korea Dermatology Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Application
      • 5.3.5.2.3. By End User

6. Europe Dermatology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Dermatology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Germany Dermatology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Spain Dermatology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User
  • 6.3.4. Italy Dermatology Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End User
  • 6.3.5. United Kingdom Dermatology Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End User

7. North America Dermatology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Dermatology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Mexico Dermatology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Canada Dermatology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User

8. South America Dermatology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Dermatology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Argentina Dermatology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Colombia Dermatology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User

9. Middle East and Africa Dermatology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Dermatology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Saudi Arabia Dermatology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. UAE Dermatology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User
  • 9.3.4. Egypt Dermatology Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By Application
      • 9.3.4.2.3. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Dermatology Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. AbbVie Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Pfizer Inc.
• 14.3. GSK plc
• 14.4. LEO Pharma A/S
• 14.5. Sun Pharmaceutical Industries Ltd
• 14.6. Galderma S.A.
• 14.7. Amgen Inc.
• 14.8. DermBiont, Inc.
• 14.9. Johnson & Johnson Services Inc.
• 14.10.Roivant Sciences Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer